Across TCGA pan-cancer cohorts, FRG2IP RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated FRG2IP data layer.
The strongest signal is observed in thymoma (THYM), where higher FRG2IP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FRG2IP expression acts as an unfavorable survival marker.
THYM, UCS, and KIRC are the cancer types where FRG2IP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.